Preliminary experience with a modified premedication protocol that included intravenous diphenhydramine and calcium bromide for the prophylaxis of paclitaxel-related hypersensitivity reactions

Author： Sasada Shinji   Hirashima Tomonori   Nakamura Yukiko   Takimoto Takayuki   Furukawa Mitsugi   Kobayashi Masashi   Nitta Takashi   Matsui Kaoru   Kawase Ichiro  

Publisher： Springer Publishing Company

ISSN： 1341-9625

Source： International Journal of Clinical Oncology, Vol.12, Iss.4, 2007-08, pp. : 274-278

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

A Comparison of Two Prophylactic Regimens for Hypersensitivity Reactions to Paclitaxel

By Kwon J.S.   Elit L.   Finn M.   Hirte H.   Mazurka J.   Moens F.   Trim K.  

Gynecologic Oncology, Vol. 84, Iss. 3, 2002-03 ,pp. : 420-425

Elsevier

Access to resources Recommend Favorite

Single-Dose Dexamethasone Paclitaxel Premedication

By Micha J.P.   Rettenmaier M.A.   Dillman R.   Fraser P.   Birk C.   Brown J.V.  

Gynecologic Oncology, Vol. 69, Iss. 2, 1998-05 ,pp. : 122-124

Elsevier

Access to resources Recommend Favorite

Hypersensitivity Reactions and the Utility of Oral and Intravenous Desensitization in Patients with Gynecologic Malignancies

By Robinson J.B.   Singh D.   Bodurka-Bevers D.C.   Wharton J.T.   Gershenson D.M.   Wolf J.K.  

Gynecologic Oncology, Vol. 82, Iss. 3, 2001-09 ,pp. : 550-558

Elsevier

Access to resources Recommend Favorite

Initial experience with a novel desensitization strategy for carboplatin-associated hypersensitivity reactions: carboplatin-hypersensitivity reactions

By Markman Maurie   Hsieh Fred   Zanotti Kristine   Webster Kenneth   Peterson Gertrude   Kulp Barbara   Spicel Ann   Belinson Jerome  

Journal of Cancer Research and Clinical Oncology, Vol. 130, Iss. 1, 2004-01 ,pp. : 25-28

Springer Publishing Company

Access to resources Recommend Favorite

Randomized Trial of Single Agent Paclitaxel Given Weekly Versus Every Three Weeks and with Peroral Versus Intravenous Steroid Premedication to Patients with Ovarian Cancer Previously Treated with Platinum

By Rosenberg Per   Andersson Ha˚kan   Boman Karin   Ridderheim Mona   Sorbe Bengt   Puistola Ulla   Parö Gunnar  

Acta Oncologica, Vol. 41, Iss. 5, 2002-09 ,pp. : 418-424

Informa Healthcare

Access to resources Recommend Favorite